» Articles » PMID: 31474984

MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner

Overview
Journal Front Immunol
Date 2019 Sep 3
PMID 31474984
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

MALT1 is a central signaling component in innate and adaptive immunity by regulating NF-κB and other key signaling pathways in different cell types. Activities of MALT1 are mediated by its scaffold and protease functions. Because of its role in lymphocyte activation and proliferation, inhibition of MALT1 proteolytic activity is of high interest for therapeutic targeting in autoimmunity and certain lymphomas. However, recent studies showing that protease-dead knock-in (-PD) mice suffer from autoimmune disease have somewhat tempered the initial enthusiasm. Although it has been proposed that an imbalance between immune suppressive regulatory T cells (Tregs) and activated effector CD4 T cells plays a key role in the autoimmune phenotype of -PD mice, the specific contribution of MALT1 proteolytic activity in T cells remains unclear. Using T cell-conditional protease-dead knock-in (-PDT) mice, we here demonstrate that MALT1 has a T cell-intrinsic role in regulating the homeostasis and function of thymic and peripheral T cells. T cell-specific ablation of MALT1 proteolytic activity phenocopies mice in which MALT1 proteolytic activity has been genetically inactivated in all cell types. The -PDT mice have a reduced number of Tregs in the thymus and periphery, although the effect in the periphery is less pronounced compared to full-body -PD mice, indicating that also other cell types may promote Treg induction in a MALT1 protease-dependent manner. Despite the difference in peripheral Treg number, both T cell-specific and full-body -PD mice develop ataxia and multi-organ inflammation to a similar extent. Furthermore, reconstitution of the full-body -PD mice with T cell-specific expression of wild-type human eliminated all signs of autoimmunity. Together, these findings establish an important T cell-intrinsic role of MALT1 proteolytic activity in the suppression of autoimmune responses.

Citing Articles

MALT1 substrate cleavage: what is it good for?.

Moud B, Ober F, ONeill T, Krappmann D Front Immunol. 2024; 15:1412347.

PMID: 38863711 PMC: 11165066. DOI: 10.3389/fimmu.2024.1412347.


Translational Studies Using the MALT1 Inhibitor ()-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer.

Di Pilato M, Gao Y, Sun Y, Fu A, Grass C, Seeholzer T J Immunother Precis Oncol. 2023; 6(2):61-73.

PMID: 37214210 PMC: 10195017. DOI: 10.36401/JIPO-22-18.


Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing.

Wittner L, Wagener L, Wiese J, Stolzer I, Krug S, Naschberger E Int J Mol Sci. 2023; 24(8).

PMID: 37108564 PMC: 10138456. DOI: 10.3390/ijms24087402.


TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functions.

ONeill T, Gewies A, Seeholzer T, Krappmann D Front Immunol. 2023; 14:1111398.

PMID: 36761777 PMC: 9902345. DOI: 10.3389/fimmu.2023.1111398.


Combining precision oncology and immunotherapy by targeting the MALT1 protease.

Mempel T, Krappmann D J Immunother Cancer. 2022; 10(10).

PMID: 36270731 PMC: 9594517. DOI: 10.1136/jitc-2022-005442.


References
1.
Rodriguez C, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R . High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet. 2000; 25(2):139-40. DOI: 10.1038/75973. View

2.
Tran T, Wilson B, Henrich C, Staudt L, Krumpe L, Smith E . Secondary Metabolites from the Fungus Dictyosporium sp. and Their MALT1 Inhibitory Activities. J Nat Prod. 2019; 82(1):154-162. PMC: 7462088. DOI: 10.1021/acs.jnatprod.8b00871. View

3.
Afonina I, Elton L, Carpentier I, Beyaert R . MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression. FEBS J. 2015; 282(17):3286-97. DOI: 10.1111/febs.13325. View

4.
Hailfinger S, Lenz G, Ngo V, Posvitz-Fejfar A, Rebeaud F, Guzzardi M . Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2009; 106(47):19946-51. PMC: 2785272. DOI: 10.1073/pnas.0907511106. View

5.
Scott D, Hatcher J, Liu H, Fu M, Du G, Fontan L . Quinoline and thiazolopyridine allosteric inhibitors of MALT1. Bioorg Med Chem Lett. 2019; 29(14):1694-1698. DOI: 10.1016/j.bmcl.2019.05.040. View